Dr. Daniel John Melzer is a pharmacist who is specialized in Oncology in Tampa, Florida. Patients can reach him at 12902 Magnolia Drive, Tampa or contact him on 813-745-7695. Active license number of Dr. Daniel John Melzer is 38021 for Oncology in Florida. Dr. Daniel John Melzer is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Daniel John Melzer speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Daniel John Melzer
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
12902 Magnolia Drive, Tampa, Florida, 33612-9497
Phone:
813-745-7695
Fax:
813-745-6737
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Daniel John Melzer are as mentioned below.
NPI Number:
1447472089
NPI Enumeration Date:
03 May, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Daniel John Melzer are as mentioned below.
Specialization
License Number
State
Status
Oncology
38021
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
12791 93rd Street, Largo, Florida
Zip:
33773-1248
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Daniel John Melzer at 12902 Magnolia Drive, Tampa, Florida or can call on phone at 813-745-7695.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.